Cargando…
Molecular imaging of T cell co-regulator factor B7-H3 with (89)Zr-DS-5573a
B7-H3 is a transmembrane protein widely expressed in a variety of cancers and has been shown to play a role in anti-tumor immunity. This study aims to develop a molecular imaging probe to identify B7-H3 expression in tumors and to develop (89)Zr-DS-5573a as a theranostic that could aid patient selec...
Autores principales: | Burvenich, Ingrid Julienne Georgette, Parakh, Sagun, Lee, Fook-Thean, Guo, Nancy, Liu, Zhanqi, Gan, Hui Kong, Rigopoulos, Angela, O'Keefe, Graeme Joseph, Gong, Sylvia Jie, Goh, Yit Wooi, Tochon-Danguy, Henri, Scott, Fiona Elizabeth, Kotsuma, Masakatsu, Hirotani, Kenji, Senaldi, Giorgio, Scott, Andrew Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096400/ https://www.ncbi.nlm.nih.gov/pubmed/30128047 http://dx.doi.org/10.7150/thno.25575 |
Ejemplares similares
-
In Vitro and In Vivo Evaluation of (89)Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy
por: Burvenich, Ingrid J.G., et al.
Publicado: (2016) -
l-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
por: Lee, Fook T., et al.
Publicado: (2016) -
Development of DS‐5573a: A novel afucosylated mAb directed at B7‐H3 with potent antitumor activity
por: Nagase‐Zembutsu, Akiko, et al.
Publicado: (2016) -
Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers
por: Burvenich, Ingrid J. G., et al.
Publicado: (2016) -
Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016)